治疗教育计划对突尼斯高血压患者知识的影响:随机对照试验
Fatma Turki1, Imen Turki2, Jihen Jedidi3,4
1Doctoral Commission "Health Sciences", Faculty of Medicine of Sousse, University of Sousse.
Annals of medicine and surgery (2012)
|November 11, 2024
概括
一个新的教育计划显著改善了突尼斯患者的高血压知识. 干预组的理解程度显著提高,突出了患者教育对管理这种普遍疾病的重要性.
科学领域:
- 心脏病学 心脏病学
- 公共卫生 公共卫生
- 医学教育 医学教育
背景情况:
- 高血压是全球主要的一种非传染性疾病.
- 有效的管理依赖于对患者的持续治疗教育.
- 低患者知识对高血压控制构成重大障碍.
研究的目的:
- 评估突尼斯患者对高血压的基线知识.
- 评估教育干预措施在改善高血压知识方面的有效性.
- 确定加强患者教育对疾病管理的影响.
主要方法:
- 一项随机对照试验,涉及突尼斯639名高血压患者.
- 实验组接受了标准的护理以及教育计划.
- 对照组只接受了标准的医疗护理.
- 使用高血压知识水平量表 (HK-LS) 调查问卷收集的数据.
主要成果:
- 最初,只有12.1%的患者有良好的高血压知识 (P=0.57).
- 干预后,63.6%的实验组表现出良好的知识,而对照组的11.4% (P<0.001).
- 实验组的HK-LS得分从58.49%显著改善到76.94% (P<0.0001),而对照组没有显著变化.
- 在大多数知识维度中都发现了改善,但不包括治疗特定知识.
结论:
- 在突尼斯患者中,基线高血压知识特别低.
- 该教育计划有效地增强了与疾病相关的知识.
- 这种教育方法对于改善高血压管理和患者的治疗结果至关重要.
相关概念视频
Errors occurring during blood pressure monitoring
605
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...
605
Factors affecting Blood pressure
3.0K
Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Physiological Factors:
3.0K
Hypertension and Regulation of Blood Pressure
1.9K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.9K
Alterations in Blood Pressure
1.2K
Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
1.2K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
481
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
481
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
141
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
141


